These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30648635)

  • 1. The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease.
    Cerón S; North BJ; Taylor SA; Leib DA
    Virology; 2019 Mar; 529():23-28. PubMed ID: 30648635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING agonists induce an innate antiviral immune response against hepatitis B virus.
    Guo F; Han Y; Zhao X; Wang J; Liu F; Xu C; Wei L; Jiang JD; Block TM; Guo JT; Chang J
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1273-81. PubMed ID: 25512416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential.
    Prantner D; Perkins DJ; Lai W; Williams MS; Sharma S; Fitzgerald KA; Vogel SN
    J Biol Chem; 2012 Nov; 287(47):39776-88. PubMed ID: 23027866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo.
    Shirey KA; Nhu QM; Yim KC; Roberts ZJ; Teijaro JR; Farber DL; Blanco JC; Vogel SN
    J Leukoc Biol; 2011 Mar; 89(3):351-7. PubMed ID: 21084628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired STING Pathway in Human Osteosarcoma U2OS Cells Contributes to the Growth of ICP0-Null Mutant Herpes Simplex Virus.
    Deschamps T; Kalamvoki M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarization.
    Downey CM; Aghaei M; Schwendener RA; Jirik FR
    PLoS One; 2014; 9(6):e99988. PubMed ID: 24940883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation.
    Temizoz B; Shibahara T; Hioki K; Hayashi T; Kobiyama K; Lee MSJ; Surucu N; Sag E; Kumanogoh A; Yamamoto M; Gursel M; Ozen S; Kuroda E; Coban C; Ishii KJ
    Front Immunol; 2024; 15():1353336. PubMed ID: 38533502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Stimulator of Interferon Genes (STING) and Sjögren Syndrome.
    Papinska J; Bagavant H; Gmyrek GB; Sroka M; Tummala S; Fitzgerald KA; Deshmukh US
    J Dent Res; 2018 Jul; 97(8):893-900. PubMed ID: 29505322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes Simplex Virus 1 γ
    Pan S; Liu X; Ma Y; Cao Y; He B
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
    Zhang D; Su C; Zheng C
    J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.
    Conlon J; Burdette DL; Sharma S; Bhat N; Thompson M; Jiang Z; Rathinam VA; Monks B; Jin T; Xiao TS; Vogel SN; Vance RE; Fitzgerald KA
    J Immunol; 2013 May; 190(10):5216-25. PubMed ID: 23585680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fever-range hyperthermia promotes cGAS-STING pathway and synergizes DMXAA-induced antiviral immunity.
    Khan IU; Brooks G; Guo NN; Chen J; Guo F
    Int J Hyperthermia; 2021; 38(1):30-37. PubMed ID: 33444507
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrinsic innate immunity fails to control herpes simplex virus and vesicular stomatitis virus replication in sensory neurons and fibroblasts.
    Rosato PC; Leib DA
    J Virol; 2014 Sep; 88(17):9991-10001. PubMed ID: 24942587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1.
    Parker ZM; Murphy AA; Leib DA
    J Virol; 2015 Nov; 89(21):11080-91. PubMed ID: 26311879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated Kinase (AMPK) Promotes Innate Immunity and Antiviral Defense through Modulation of Stimulator of Interferon Genes (STING) Signaling.
    Prantner D; Perkins DJ; Vogel SN
    J Biol Chem; 2017 Jan; 292(1):292-304. PubMed ID: 27879319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles Released by Herpes Simplex Virus 1-Infected Cells Block Virus Replication in Recipient Cells in a STING-Dependent Manner.
    Deschamps T; Kalamvoki M
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of C7-functionalized DMXAA derivatives as potential human-STING agonists.
    Hwang J; Kang T; Lee J; Choi BS; Han S
    Org Biomol Chem; 2019 Feb; 17(7):1869-1874. PubMed ID: 30117503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING-Mediated Interferon Induction by Herpes Simplex Virus 1 Requires the Protein Tyrosine Kinase Syk.
    Wang C; Sharma N; Veleeparambil M; Kessler PM; Willard B; Sen GC
    mBio; 2021 Dec; 12(6):e0322821. PubMed ID: 34933455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
    Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
    PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Cao Z; Baguley BC; Ching LM
    Cancer Res; 2001 Feb; 61(4):1517-21. PubMed ID: 11245459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.